ChinaLink ESGt

ChinaLink is a leading venture capital firm headquartered in Shanghai. Established in 2007, ChinaLink specializes in investing in late-stage seed technology companies across various sectors such as AI, cloud computing, biotech, healthcare, smart cities, renewable energy, and sustainable mobility. As the venture capital arm of The Gamma Consortium, managing assets exceeding $5 billion, including the esteemed China New Era Technology Fund (CNETF), we are positioned at the forefront of innovation and investment. Our portfolio boasts transformative companies like Alibaba, Tencent, and SpaceX, alongside groundbreaking startups like CAS and Chase Therapeutics, which are addressing critical global challenges. ChinaLink has invested in entrepreneurs, scientists, Nobel laureates and visionaries who have built the companies that today are changing the world forever.